Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02879006
Recruitment Status : Active, not recruiting
First Posted : August 25, 2016
Last Update Posted : August 12, 2020
Sponsor:
Information provided by (Responsible Party):
Xiu-Min Li, Icahn School of Medicine at Mount Sinai

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2020